Description
Latin name
SUPLAZYNE
Release form
Injection in a syringe.
packaging In blister strip packaging 1 disposable syringe. In a cardboard box 1 blister strip packaging.
Pharmacological action of
Suplazin contains hyaluronic acid. Hyaluronic acid is a physiological component of synovial fluid and plays a major role in supporting and lubricating the joint. It is the prototype of a wide range of biopolymers (glycosaminoglycans and mucopolysaccharides), important components of all extracellular structures, including cartilage and synovial fluid. The active component of the drug is a specific fraction of hyaluronic acid with a certain length of a high purity molecular chain. The introduction of the drug into the synovial cavity leads to the normalization of the condition of the joint after arthrocentesis.
Indications
– Synovial fluid replacement after arthrocentesis.
– Osteoarthritis to treat pain and improve joint function, as the drug improves the rheological properties of synovial fluid.
Contraindications
Hypersensitivity to the components of the drug.
Ingredients
1 syringe contains: sodium salt of hyaluronic acid 20 mg, phosphate buffer 2 ml.
Dosing and Administration
Warm to room temperature before use. Depending on the size of the joint, up to 2 ml of the drug can be administered intraarticularly. The standard recommended dosage regimen is weekly administration of the drug for 3 weeks, however, in the chronic process, therapy can be continued for up to 6 weeks. Under aseptic conditions, up to 2 ml of the drug is injected intraarticularly into the affected joint. At the same time, several joints can be treated with the drug. Dispose of any unused drug residues in a vial or syringe.
Storage conditions
Store at a temperature of 4 to 30 ° C. Do not freeze.
Shelf life
3 years.
active substance
Hyaluronate Sodium
lekarstvennaja form
suspensions for
